The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 30, No. 6, pp. 678-679.
© 1996 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williford, S.
Right arrow Articles by King, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williford, S.
Right arrow Articles by King, T

Research Articles

Interferon alfa for macular degeneration

SL Williford and T King

Clinical studies demonstrate that interferon alfa has little benefit in treating CNV secondary to macular degeneration. However, it may be useful in the treatment of choroidal and retinal hemangiomas, diabetic and post-vein occlusion retinopathy, and retinopathy of prematurity.




homecopy help contact us subscription past issues search current issue
Copyright © 1996 by Harvey Whitney Books Company.